Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
09. Januar 2023 08:30 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
23. September 2021 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the...
Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update
13. September 2021 16:05 ET
|
Rani Therapeutics, LLC
- IPO in July 2021 raised $84.3 million in gross proceeds -- Talat Imran Appointed Chief Executive Officer -- Enhanced leadership team with key management and board of directors’ appointments - SAN...
Rani Therapeutics Announces Appointment of Eric Groen as General Counsel
09. September 2021 08:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on advancing...
Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
13. August 2021 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing...
Rani Therapeutics Announces Pricing of Initial Public Offering
30. Juli 2021 08:56 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., July 30, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing technologies to...